Richard H. Bell
- Oncology top 0.5%
- Surgery top 1%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 1%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- Thomas E. AdrianDavid CameronMarina TalamontiRobert J. HyeL. D. BrittFrank R. LewisThomas W. BiesterRobert S. Rhodes
- Topics
- Pancreatic and Hepatic Oncology Research (28 papers)HER2/EGFR in Cancer Research (22 papers)Bone health and treatments (15 papers)
- Cited by
- OncologyCancer ResearchSurgery
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Richard H. Bell
159 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Oncology 3.5k
- Surgery 2.1k
- Molecular Biology 1.5k
- Radiology, Nuclear Medicine and Imaging 1.0k
- Pulmonary and Respiratory Medicine 967
Countries citing papers authored by Richard H. Bell
This map shows the geographic impact of Richard H. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard H. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard H. Bell more than expected).
Fields of papers citing papers by Richard H. Bell
This network shows the impact of papers produced by Richard H. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard H. Bell. The network helps show where Richard H. Bell may publish in the future.
Co-authorship network of co-authors of Richard H. Bell
This figure shows the co-authorship network connecting the top 25 collaborators of Richard H. Bell. A scholar is included among the top collaborators of Richard H. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard H. Bell. Richard H. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trialbreakdown → | 688 |
| 3 | 17 | |
| 4 | 1 | |
| 5 | 30 | |
| 6 | 4 | |
| 7 | 18 | |
| 8 | The impact of the HIPAA Privacy Rule on collegiate sport professionals | 1 |
| 9 | 17 | |
| 10 | 166 | |
| 11 | 2 | |
| 12 | 11 | |
| 13 | A NEW ROLE FOR PUBLIC HEALTH IN TRANSPORTATION CREATING AND SUPPORTING COMMUNITY MODELS FOR ACTIVE TRANSPORTATION | 1 |
| 14 | Digestive tract surgery : a text and atlas | 12 |
| 15 | Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myelomabreakdown → | 780 |
| 16 | Simone Weil's philosophy of culture : readings toward a divine humanity | 11 |
| 17 | 17 | |
| 18 | 3 | |
| 19 | The origin of Islam in its Christian environment : the Gunning lectures, Edinburgh University 1925 | 1 |
| 20 | A study of the image of the American character as presented in the selected network television dramas / | 1 |
About Richard H. Bell
Richard H. Bell is a scholar working on Oncology, Religious studies and Surgery, having authored 167 papers that have together received 7.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (28 papers), HER2/EGFR in Cancer Research (22 papers) and Bone health and treatments (15 papers). The work is most often cited by research in Oncology (3.5k citations), Cancer Research (832 citations) and Surgery (2.1k citations). Richard H. Bell has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Thomas E. Adrian, David Cameron, Marina Talamonti, Robert J. Hye, L. D. Britt, Frank R. Lewis, Thomas W. Biester, Robert S. Rhodes, Marshall J. Orloff and Mustafa Khasraw. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.